The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

‘Dramatic’ inroads towards aggressive mind most cancers— Harvard Gazette

A collaborative challenge to deliver the promise of cell remedy to sufferers with a lethal type of mind most cancers has proven dramatic...

Shannen Doherty admitted to ‘feeling hopeful’ about her chemo remedy simply weeks earlier than most cancers dying at 53

SHANNEN Doherty, star of Beverly Hills, 90210, admitted to feeling hopeful about her most cancers remedy simply weeks earlier than her dying.The Charmed...

Accelerating pediatric most cancers analysis by groundbreaking analysis and volunteerism

For greater than 25 years, Leidos has partnered with many Nationwide Institutes of Well being (NIH) facilities and institutes, together with the Nationwide...

Charmed star Shannen Doherty dies aged 53 after breast most cancers prognosis

Printed 13:55 14 Jul 2024 GMT+1Shannen Doherty was recognized with breast most cancers in 2015 Shannen Doherty has handed away on the age...

Well being Canada approves Tagrisso® with the addition of chemotherapy for sufferers with EGFR-mutated superior lung most cancers

Approval primarily based on FLAURA2 outcomes, which confirmed Tagrisso plus chemotherapy prolonged median progression-free survival by almost 9 months in comparison with customary...

Hot Topics